LOTIS-2 Follow-Up Analysis: Updated Results from a Phase 2 Study of Loncastuximab Tesirine (Lonca) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma-MedSci.cn

LOTIS-2 Follow-Up Analysis: Updated Results from a Phase 2 Study of Loncastuximab Tesirine (Lonca) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Kahl, BS; Hamadani, M; Caimi, PF; Carlo-Stella, C; Ai, WY; Alderuccio, JP; Ardeshna, KM; Hess, B; Radford, J; Solh, M; Stathis, A; Feingold, J; Ungar, D; Qin, YJ; He, S; Zinzani, PL

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021; 21 (): S377

科室
- - 订阅+
  - 更多科室
工具
服务